Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-294-0 | CAS number: 105-39-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
- Endpoint:
- carcinogenicity
- Remarks:
- subcutaneous
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: The subcutaneous route is not relevant and the animals were only administered the substance once a week.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 974
Materials and methods
- Principles of method if other than guideline:
- Administered by subcutaneous route into female ICR/Ha Swiss mice, ethyl chloroacetate was tested for carcinogenic activity. The mice were given weekly injections in the left flank. The treatments were continued throughout the test. The incidence of sarcomas at the site of injection and tumors at sites distant from the area of administration was tabulated for test and control groups.
- GLP compliance:
- no
Test material
- Reference substance name:
- Ethyl chloroacetate
- EC Number:
- 203-294-0
- EC Name:
- Ethyl chloroacetate
- Cas Number:
- 105-39-5
- Molecular formula:
- C4H7ClO2
- IUPAC Name:
- ethyl 2-chloroacetate
- Details on test material:
- - Name of test material (as cited in study report): Ethyl chloroacetate
- Source: Eastman Organic Chemicals, Rochester, N.Y.
- Method of purification: Distillation, bp 138-140° C/760 mm.
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: ICR/Ha Swiss
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: A.R. Schmidt-Sprague-Dawley, Madison, Wisc.
- Age at study initiation: 6-8 weeks old
- Housing: The mice were housed, 10 to a cage, on sterile, hardwood chips (Iso-Dry, Fisher & Son, Bound Brook, N.J.) in stainless-steel cages 11x7x6 inches high.
- Diet (e.g. ad libitum): Purina Laboratory Chow, ad libitum
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22-24 ºC
Administration / exposure
- Route of administration:
- subcutaneous
- Vehicle:
- other: tricaprylin
- Details on exposure:
- The mice were given injections in the left flank with a 26-gauge, %-inch stainless-steel needIe (Becton, Dickinson & Co., Rutherford, N.J.), mounted on a 1-cc glass tip tubercuIin syringe graduated to 0.01 mL.
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 580 days
- Frequency of treatment:
- Once a week
- Post exposure period:
- All compounds were used in well-ventilated hoods, and the mice were housed there for at least 3 hours after treatment.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
1 mg/0.05 mL Tricaprylin
Basis:
nominal conc.
- No. of animals per sex per dose:
- 50 female mice per dose
- Control animals:
- yes, concurrent no treatment
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: The dosages used in all experiments were based on short-term toxicity evaluations (for 4 wk), and the highest possible doses that gave minimal cytotoxic effects were used.
- Positive control:
- It was used 0.3 mg of ß-propiolactone per 0.05 mL tricaprylin .
Examinations
- Observations and examinations performed and frequency:
- All animals were examined regularly and the findings were recorded monthly.
BODY WEIGHT: Yes
- Time schedule for examinations: Weighed monthly - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes
Animals in poor health or with large tumor masses were killed.
Except for the cranial region, animals were completely autopsied at the end of the experiment or at death. Although samples of all tissues and organs
were not taken from each animal on test, the autopsies were done carefully and samples of all abnormalappearing tissues and organs were excised for histopathologic diagnosis. All tissue sections were fixed in 10% formalin, processed, blocked in paraffin, and stained with hematoxylin and eosin for histopathologic examination. - Statistics:
- The incidence of sarcomas at the site of injection and tumors at sites distant from the area of administration was tabulated for all test and control groups. Significance values (P) were calculated for the most common distant tumors. In both no-treatment control groups and test groups, the cut-off point for significance was P= 0.05. If a compound had a P value of 0.05, it was considered borderline. P values > 0.05 were considered not significant. Any compound with a P value < 0.05 was considered to have significant tumorigenic activity. All statistical data were computed based on 1 degree of freedom.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Mortality:
- mortality observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Details on results:
- They found no significant difference between the incidence of distant tumors in treated animals and the incidence in no-treatment control groups.
One of 50 mice had a local sarcoma in the group given tricaprylin only. No malignant tumors were observed in control group.
The positive control (3-propiolactone) resulted in 28 sarcomas, 4 squamous cell carcinomas and 2 adenocarcinomas of breast origin near the injection site.
Median survival time: 471 days.
- Relevance of carcinogenic effects / potential:
- They found no significant difference between the incidence of distant tumors in treated animals and the incidence in no-treatment control groups.
Effect levels
open allclose all
- Dose descriptor:
- dose level: 1 mg/0.05 mL tricaprylin
- Effect level:
- 1 other: of 50
- Sex:
- female
- Basis for effect level:
- other: p> 0.05
- Remarks on result:
- other:
- Remarks:
- Effect type: other: sarcomas (migrated information)
- Dose descriptor:
- dose level: 1 mg/0.05 mL tricaprylin
- Effect level:
- 0 other: of 50
- Sex:
- female
- Basis for effect level:
- other: p> 0.05
- Remarks on result:
- other:
- Remarks:
- Effect type: other: squamous cell carcinomas (migrated information)
- Dose descriptor:
- dose level: 1 mg/0.05 mL tricaprylin
- Effect level:
- 0 other: of 50
- Sex:
- female
- Basis for effect level:
- other: p> 0.05
- Remarks on result:
- other:
- Remarks:
- Effect type: other: adenocarcinomas (migrated information)
Applicant's summary and conclusion
- Conclusions:
- They found no significant difference between the incidence of distant tumors in treated animals and the incidence in no-treatment control groups. On the basis of their findings the authors classified ethyl chloroacetate as non-carcinogenic under the prevailing test conditions.
- Executive summary:
Administered by subcutaneous route into female ICR/Ha Swiss mice, ethyl chloroacetate was tested for carcinogenic activity. The dose used was 1 mg/0.05 mL tricaprylin and the mice were given weekly injections in the left flank. The treatments were continued throughout the test. The incidence of sarcomas at the site of injection and tumors at sites distant from the area of administration was tabulated for test and control groups.
One of 50 mice had a local sarcoma in the group given tricaprylin only. No malignant tumors were observed in no treatment group. The positive control (3-propiolactone) resulted in 28 sarcomas, 4 squamous cell carcinomas and 2 adenocarcinomas of breast origin near the injection site.
They found no significant difference between the incidence of distant tumors in treated animals and the incidence in no-treatment control groups (p>0.05). On the basis of their findings the authors classified ethyl chloroacetate as non-carcinogenic under the prevailing test conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.